Category: St. Jude MedicalSyndicate content

Press Release: St. Jude Medical announces CE Mark approval and 1st use of the FlexAbility ablation catheter

July 22, 2014 by MassDevice

European approval of next-generation ablation catheter further strengthens St. Jude Medical's fast-growing ablation technology portfolio.

Press Release: St. Jude Medical announces CE Mark approval and first use of the FlexAbility ablation catheter

St. Jude lands E.U. nod for flexible ablation catheter

July 22, 2014 by Arezu Sarvestani

Minnesota medtech giant St. Jude Medical touts 1st use of its FlexAbility ablation catheter after landing approval from European regulators.

St. Jude lands E.U. nod for flexible ablation catheter

European regulators put their stamp of approval on St. Jude Medical's (NYSE:STJ) new FlexAbility ablation catheter, paving the way to 1st use of the next-generation device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Study links St. Jude's Medical's Riata lead externalizations to electrical failures

July 17, 2014 by Brad Perriello

A Danish study of St. Jude Medical's recalled Riata and Riata ST defibrillator leads suggests that the externalization problem that led to the recall worsens over time and is linked to "electrical abnormalities."

Study links St. Jude's Medical's Riata lead externalizations to electrical failures

Covidien shareholder files class action lawsuit blocking company's merger with Medtronic | The week in medtech M&A

July 16, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Shareholder files class action lawsuit to block Covidien-Medtronic merger; St. Jude drops $200M on NeuroTherm for spinal pain device; Allergan renews fight against hostile Valeant takeover; Abbott to deal pharma line to Mylan for $5.3B

Shareholder files class action lawsuit to block Covidien-Medtronic merger

July 11, 2014 by Brad Perriello

Analyst: St. Jude Medical's Q2 results could signal ICD rebound

July 16, 2014 by Brad Perriello

St. Jude Medical's 2nd-quarter results, including a 2% gain for its implantable cardiac defibrillator business, could signal a rebound for the ICD sector overall, according to Leerink Partners.

Analyst: St. Jude Medical's Q2 results could signal ICD rebound

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

St. Jude drops $200M on NeuroTherm for spinal pain device

July 14, 2014 by Arezu Sarvestani

St. Jude Medical enters the spinal pain treatment arena with the $200 million cash acquisition of NeuroTherm and its radiofrequency ablation technology.

St. Jude drops $200M on NeuroTherm for spinal pain device

Minnesota-based medtech giant St. Jude Medical (NYSE:STJ) is broaching new ground in the spinal pain market with the $200 million acquisition of NeuroTherm, maker of radiofrequency ablation therapies.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp